List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 24 studies with search of:   "Keratoconjunctivitis"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
Conditions: Keratoconjunctivitis;   Conjunctivitis
Interventions: Drug: FK506;   Drug: placebo
2 Recruiting Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
Condition: Keratoconjunctivitis Sicca
Interventions: Drug: CF101;   Drug: Placebo
3 Completed Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: Pimecrolimus
4 Recruiting Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis
Condition: Vernal Keratoconjunctivitis
Intervention: Drug: cyclosporin eye drop
5 Recruiting Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment
Condition: Vernal Keratoconjunctivitis
Intervention: Drug: Lactoobacillus Rhamnosus GG
6 Completed Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis
Condition: Keratoconjunctivitis, Vernal
Intervention: Drug: N-acetyl-aspartyl-glutamate (NAAXIA Sine)
7 Completed Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
Conditions: Keratoconjunctivitis;   Conjunctivitis
Intervention: Drug: FK506
8 Completed Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops
Conditions: Keratoconjunctivitis Sicca;   Sjogren's Syndrome
Intervention: Drug: Cyclosporin A
9 Recruiting The Pathogenesis of Superior Limbic Keratoconjunctivitis
Condition: Superior Limbic Keratoconjunctivitis
Intervention:
10 Recruiting Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: AT01;   Drug: AT02;   Drug: AT03;   Drug: AT04
11 Completed Study of Rebamipide Eye Drops to Treat Dry Eye
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: Rebamipide
12 Completed Study of Rebamipide Eye Drops to Treat Dry Eye
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: Rebamipide
13 Completed Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
Conditions: Keratoconjunctivitis Sicca;   Sjogren's Syndrome;   Lupus Erythematosus, Systemic;   Arthritis, Rheumatoid;   Scleroderma, Systemic
Intervention: Drug: Ophthalmic Emulsion
14 Active, not recruiting Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: cyclosporine ophthalmic emulsion 0.05%, artificial tears
15 Recruiting Goblet Cell Response and Dry Eye Symptoms After PRK and LASIK
Condition: Keratoconjunctivitis Sicca
Interventions: Procedure: PRK with conjunctival impression cytology before and after surgery;   Procedure: LASIK with conjunctival impression cytology before and after surgery
16 Completed Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points
Condition: Keratoconjunctivitis Sicca
Interventions: Drug: Systane Ocular Drops (OTC);   Drug: Placebo - Saline Drops
17 Recruiting Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
Conditions: Dry Eye Disease;   Keratoconjunctivitis Sicca
Interventions: Drug: Lotemax;   Drug: Restasis
18 Recruiting Effect of B-Cell Depletion in Patients With Primary Sjögren's Syndrome
Conditions: Primary Sjögren's Syndrome;   Xerostomia;   Hyposalivation;   Keratoconjunctivitis Sicca;   Fatigue
Interventions: Drug: MabThera (rituximab);   Drug: Rituximab, Mabthera
19 Completed Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: INS365 Ophthalmic Solution
20 Completed Tear Film Break-up Time After Instillation of Artificial Tears
Condition: Keratoconjunctivitis Sicca
Interventions: Drug: glycerin;   Drug: polyethylene glycol 400/propylene glycol

Previous Page Studies Shown (1-20) Next (21-24)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services